| Type | MGI:General | Description | MOG35-55 treated mice exhibit delayed onset and reduced clinical score, reduced leukocyte spinal cord infiltration, and decreased TH1 and TH17 cells in the spinal cord and spleen compared with wild-type mice and Vsig4tm1Gne homozygotes |
